RGCC is a specialist medical genetics company, established in 2004 with headquarters in Switzerland.
We are experts in developing and providing personalised cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances.
We are actively involved in pharmaceutical research and development. Our facilities are equipped with the most technologically advanced equipment and specialised software for data analysis.
RGCC is a global organisation, and we work in collaboration with branch offices and distributors to provide a worldwide service.
Our work can be divided into two main sectors.
- Our testing services, which detect tumours that are sensitive and resistant to chemotherapy treatment using microarray technology. This uses high throughput screening to provide an automated and fast method to process blood samples and screen different types of libraries, including combinatorial chemistry, genomics, protein and peptide libraries.
- Our analytical services, which includes detecting, immunophenotyping and isolating circulating tumour cells, using flow cytometers.
RGCC is a global organisation and we work in collaboration with branch offices and distributors to provide a worldwide service. Our head office is located in Switzerland and we have state-of-the-art laboratory facilities based around the world.